STEMONIX, INC.

Profile

Company Names

STEMONIX, INC.

Addresses

13300 67TH AVE N, MAPLE GROVE, MN 55311

13300 67TH AVENUE NORTH, MAPLE GROVE, MN 55311

1635 HENNEPIN AVE, STE. 200, MINNEAPOLIS, MN 55403

9081 WAVERLY COURT, EDEN PRAIRIE, MN 55347

Phone Numbers

612-802-9299
612-804-8225

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2014

State Incorporated:

MINNESOTA

Total Amount Raised:

$14,576,215.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2020-05-04 
$100,000.00 
$10,890,965.00 
$10,790,965.00 
Debt 
6
2019-09-27 
$2,066,366.00 
$6,000,000.00 
$3,933,634.00 
Equity 
5
2018-08-08 
$1,428,760.00 
$12,000,000.00 
$10,571,240.00 
Equity 
4
2017-10-24 
$4,930,000.00 
$6,000,000.00 
$1,070,000.00 
 
3
2017-02-24 
$2,412,489.00 
$6,000,000.00 
$3,587,511.00 
Equity 
2
2016-07-22 
$2,500,000.00 
$2,500,000.00 
$0.00 
Debt 
1
2015-12-29 
$1,138,600.00 
$2,300,000.00 
$1,161,400.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BLAKE 
 
ANSON 
EXECUTIVE OFFICER
MARCUS 
 
BOEHM 
DIRECTOR
DAVID 
 
BUCHE 
EXECUTIVE OFFICER
RYAN 
 
GORDON 
EXECUTIVE OFFICER
KEVIN 
 
GUNDERSON 
DIRECTOR
PAUL 
 
HANSEN 
DIRECTOR
DIMAS 
 
JIMENEZ 
EXECUTIVE OFFICER
MURDOC 
 
KHALEGHI 
EXECUTIVE OFFICER
ANDREW 
 
LAFRENCE 
EXECUTIVE OFFICER, PROMOTER
SRIRAM 
 
NADATHUR 
DIRECTOR
PATRICK 
 
O-SHAUGHNESSY 
DIRECTOR
MATTHEW 
 
PERIS 
EXECUTIVE OFFICER
ROBERT 
 
PETCAVICH 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
STEVEN 
 
SNYDER 
DIRECTOR
YUNG-PING 
 
YEH 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
FABIAN 
 
ZANELLA 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-05-04 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-09-27 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-08 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2017-10-24 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-10-24 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-02-24 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-07-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-07-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-12-29 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
NORTH CAPITAL PRIVATE SECURITIES CORPORATION
NONE
NONE
BOUSTEAD SECURITIES, LLC
NONE
NONE
BOUSTEAD SECURITIES, LLC
NONE
NONE
ROTH CAPITAL PARTNERS
CEDAR POINT CAPITAL, LLC
TODD C. JOHNSON